Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis.

scientific article published on 2 October 2012

Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1035037512
P356DOI10.1186/AR4042
P932PMC publication ID3580516
P698PubMed publication ID23031278
P5875ResearchGate publication ID231860260

P50authorDerek L MatteyQ59591523
P2093author name stringPeter T Dawes
Nicola B Nixon
P2860cites workThe american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activityQ33359741
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisQ34182804
The mortality of rheumatoid arthritisQ34338843
Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health StudyQ35551075
Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species.Q35868987
Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.Q36246052
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.Q37224482
The widening mortality gap between rheumatoid arthritis patients and the general populationQ38459919
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery diseaseQ40393362
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular diseaseQ40596987
Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of diseaseQ42279641
Pulmonary matrix metalloproteinase excess in hospital-acquired pneumoniaQ42437142
High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritisQ42625036
How to reduce morbidity and mortality from chest infections in rheumatoid arthritisQ42904895
Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritisQ43709155
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.Q43769669
Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factorQ45337810
Acute lower respiratory tract infections in patients with rheumatoid arthritis.Q51104178
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.Q51479961
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo.Q51707967
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.Q51835885
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.Q51991843
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markQ52980619
Absence or Inhibition of Matrix Metalloproteinase–8 Decreases Ventilator-Induced Lung InjuryQ57082623
Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohortQ57804967
Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of PhysiciansQ68107428
Mortality in rheumatoid arthritisQ68126709
Prevalence of angina as assessed by a survey of prescriptions for nitratesQ69917748
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scalesQ70606503
Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosisQ71954108
Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndromeQ72991616
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onsetQ73292550
Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPDQ73538164
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritisQ73678542
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activityQ73782535
The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumoniaQ74079346
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery diseaseQ78394962
Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritisQ80123752
Prediction of mortality in rheumatoid arthritis based on disease activity markersQ81463187
Cardiovascular death in rheumatoid arthritis: a population-based studyQ81484761
MMP expression and abnormal lung permeability are important determinants of outcome in IPFQ82176972
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectorisQ82404817
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injuryQ82971574
Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritisQ83506210
Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritisQ84554453
P433issue5
P921main subjectrheumatoid arthritisQ187255
respiratory diseaseQ3286546
P304page(s)R204
P577publication date2012-10-02
P1433published inArthritis Research and TherapyQ15757229
P1476titleAssociation of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis
P478volume14

Reverse relations

cites work (P2860)
Q48100083Active matrix metalloproteinase-8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis
Q38140574Beneficial role of vitamin D3 in the prevention of certain respiratory diseases
Q35415454Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus.
Q38239828Biomarkers of cartilage and surrounding joint tissue
Q64107215Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus
Q30371254Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.
Q33898784Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium
Q64277451Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients
Q38111419Spondyloarthritis and smoking: towards a new insight into the disease
Q41553156The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions

Search more.